Helping gynecologic cancer patients discuss sexual health with their doctors
Official title: Promoting Effective Clinical Communication About Sexual Health After Gynecologic Cancer: A Randomized Controlled Trial of a Patient-Focused Intervention
Run by Fox Chase Cancer Center · NCT06904339 · Data updated 2026-11-12
This study tests if an educational video and workbook can help gynecologic cancer patients talk more openly about sexual health with their doctors and improve their overall well-being.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | Women only |
| Enrollment | 200 (estimated) |
| Sponsor | Fox Chase Cancer Center Academic / other |
| Locations | 1 site (Philadelphia, Pennsylvania) |
| Status | Recruiting |
| Started | February 20, 2025 |
| Main results expected | March 31, 2028 |
| Study ends | September 30, 2028 |
| Registry record updated | June 2, 2026 |
| Trial ID | NCT06904339 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 and older diagnosed with any stage of gynecologic cancer who are currently receiving treatment or have completed treatment within the last 10 years.
✕Probably not a fit
Patients who are unable to speak English or have significant cognitive or psychiatric issues may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This clinical trial aims to determine if an educational video and workbook can enhance communication between gynecologic cancer patients and their healthcare providers regarding sexual health concerns. Participants will be divided into two groups: one receiving the educational program along with a resource booklet, and the other receiving only the resource booklet. The study will assess whether those who engage with the educational materials discuss sexual health issues more openly and experience improvements in sexual function, anxiety, and depression. Data will be collected through surveys and audio recordings of clinic visits.
Why it matters
Potential benefit: If successful, this study could empower gynecologic cancer patients to address sexual health issues more effectively, leading to improved quality of life.
How similar studies have gone: While the specific approach of this study may be novel, similar educational interventions have shown promise in improving patient-provider communication in other healthcare contexts.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * At least 18 years old * Diagnosed with any stage (I-IV) gynecologic cancer * Receiving treatment for gynecologic cancer or completed active treatment less than 10 years ago * Attending visits in follow-up care at Fox Chase Cancer Center * Score of at least 3 on a sexual concerns screener question Exclusion Criteria: * Not able to speak English * Not willing to have clinic visit audio recorded * Eastern Cooperative Oncology Group (ECOG) score \> 2 * Overt cognitive dysfunction or psychiatric disturbance
Where it's running
-
Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States Recruiting
Study contacts
- Study coordinator: Jennifer B Reese, PhD
- Email: jennifer.reese@fccc.edu
- Phone: 215-214-3223
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Immunonutrition and Brain Monitoring to See if Delirium Happens After Gynecologic Cancer Surgery
This study tests whether a preoperative immunonutrition scoring plus intraoperative brain monitoring can help predict or relate to postoperative delirium in women aged 65 and older undergoing major gynecologic cancer surgery.
-
Prophylactic subcutaneous drainage after gynecologic cancer surgery
This study tests whether placing a small drain under the skin after gynecologic cancer surgery helps prevent wound problems in women with thicker tissue under the skin.
-
Feasibility of high-dose multimodal prehabilitation for women awaiting gynecologic cancer surgery
This study tests whether a high-dose, multimodal prehabilitation program can be delivered before gynecologic cancer surgery and whether patients prefer in-person, remote, or education-only approaches.
-
Romiplostim N01 plus ATRA for persistent chemotherapy-induced low platelets after remission from gynecologic, breast, or lung cancer
This trial tests whether adding ATRA to Romiplostim N01 helps people keep a safe platelet count after finishing chemotherapy for certain cancers.
-
Sexual well-being in people treated for gynecologic cancer and their partners
This project will follow people with gynecologic cancer and their partners to see if their sexual function changes over time using questionnaires and brief exams.
-
Personalized diet to help women with advanced gynecologic or breast cancer on ADC therapy
This study tests a personalized dietary plan versus general Mediterranean diet guidance in women with advanced gynecologic or breast cancer who are being treated with antibody-drug conjugates to see if nutrition can improve quality of life.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.